Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Charlotte Emily Goldfine, M.D.

Concepts (40)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Charlotte Goldfine's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Charlotte Goldfine has written about over time.
Nephrogenic Fibrosing Dermopathy, 1 publications between 2018 and 2018, average publication date November 2018. Drug Users, 1 publications between 2021 and 2021, average publication date February 2021. Naloxone, 1 publications between 2021 and 2021, average publication date February 2021. Clinical Clerkship, 1 publications between 2022 and 2022, average publication date January 2022. Emergency Medicine, 1 publications between 2022 and 2022, average publication date January 2022. Students, Medical, 1 publications between 2022 and 2022, average publication date January 2022. Opioid-Related Disorders, 2 publications between 2021 and 2023, average publication date February 2022. Buprenorphine, 1 publications between 2023 and 2023, average publication date February 2023. Opiate Substitution Treatment, 1 publications between 2023 and 2023, average publication date February 2023. Substance Withdrawal Syndrome, 1 publications between 2023 and 2023, average publication date February 2023. Bicarbonates, 1 publications between 2023 and 2023, average publication date June 2023. Bupropion, 1 publications between 2023 and 2023, average publication date June 2023. Sodium Bicarbonate, 1 publications between 2023 and 2023, average publication date June 2023. Adrenergic beta-Antagonists, 1 publications between 2024 and 2024, average publication date February 2024. Calcium, 1 publications between 2024 and 2024, average publication date February 2024. Calcium Channel Blockers, 1 publications between 2024 and 2024, average publication date February 2024. Vasoconstrictor Agents, 1 publications between 2024 and 2024, average publication date February 2024. Fellowships and Scholarships, 1 publications between 2024 and 2024, average publication date February 2024.

To see the data from this visualization as text, click here.
Goldfine's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (40)
Explore
_
Co-Authors (21)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.